Accordingly, the detection of positive cells by IDH1-R132H immounohistochemistry allows a clear and safe separation between low-grade glioma and reactive gliosis, and clearly supports the diagnosis of a diffusely infiltrating glioma as well as the differential diagnosis between an anaplastic glioma and a glioblastoma. Here, IDH1 is linked to central nervous system cancer.